The −7 chromosomal abnormalities with signs of myelodysplasia in chronic myeloid leukemia as a major red signal

door Cayssials, Emilie, Guilhot, François
Gepubliceerd in Haematologica (2019)

Characterization of the Different BCR-ABL Transcripts with a Single Multiplex RT-PCR

door Chasseriau, Jacques, Rivet, Jérôme, Bilan, Frédéric, Chomel, Jean-Claude, Guilhot, François, Bourmeyster, Nicolas, Kitzis, Alain
Gepubliceerd in 2004

Early onset hypercholesterolemia induced by the 2(nd)-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia

door Rea, Delphine, Mirault, Tristan, Cluzeau, Thomas, Gautier, Jean-François, Guilhot, François, Dombret, Hervé, Messas, Emmanuel
Gepubliceerd in 2014

Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

door Breccia, Massimo, Baccarani, Michele, Rosti, Gianantonio, Cottone, Francesco, Cannella, Laura, Guilhot, François, Vignetti, Marco, Efficace, Fabio
Gepubliceerd in Health Qual Life Outcomes (2017)

High rates of durable response are achieved with imatinib after treatment with interferon α plus cytarabine: results from the International Randomized Study of Interferon and STI57...

door Guilhot, François, Druker, Brian, Larson, Richard A., Gathmann, Insa, So, Charlene, Waltzman, Roger, O’Brien, Stephen G.
Gepubliceerd in 2009

Comprehensive Characterization of a Novel Intronic Pseudo-Exon Inserted within an e14/a2 BCR-ABL Rearrangement in a Patient with Chronic Myeloid Leukemia

door Sorel, Nathalie, Mayeur-Rousse, Caroline, Deverrière, Séverine, Roy, Lydia, Brottier-Mancini, Elisabeth, Guilhot, François, Turhan, Ali G., Chomel, Jean Claude
Gepubliceerd in 2010

Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial

door Guilhot, François, Hughes, Timothy P., Cortes, Jorge, Druker, Brian J., Baccarani, Michele, Gathmann, Insa, Hayes, Michael, Granvil, Camille, Wang, Yanfeng
Gepubliceerd in 2012

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

door Flamant, Stéphane, Ritchie, William, Guilhot, Joëlle, Holst, Jeff, Bonnet, Marie-Laure, Chomel, Jean-Claude, Guilhot, François, Turhan, Ali G., Rasko, John E.J.
Gepubliceerd in 2010

Efficacy of Imatinib Dose Escalation in Patients With Chronic Myeloid Leukemia in Chronic Phase

door Kantarjian, Hagop M., Larson, Richard A., Guilhot, Francois, O’Brien, Stephen G., Mone, Manisha, Rudoltz, Marc, Krahnke, Tillmann, Cortes, Jorge, Druker, Brian J.
Gepubliceerd in Cancer (2009)

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial

door Brümmendorf, Tim H, Cortes, Jorge E, de Souza, Cármino Antonio, Guilhot, Francois, Duvillié, Ladan, Pavlov, Dmitri, Gogat, Karïn, Countouriotis, Athena M, Gambacorti-Passerini, Carlo
Gepubliceerd in Br J Haematol (2015)

Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia

door Bruzzoni-Giovanelli, Heriberto, González, Juan R., Sigaux, François, Villoutreix, Bruno O., Cayuela, Jean Michel, Guilhot, Joëlle, Preudhomme, Claude, Guilhot, François, Poyet, Jean-Luc, Rousselot, Philippe
Gepubliceerd in Oncotarget (2015)

Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease

door Chomel, Jean-Claude, Bonnet, Marie-Laure, Sorel, Nathalie, Bertrand, Angelina, Meunier, Marie-Claude, Fichelson, Serge, Melkus, Michael, Bennaceur-Griscelli, Annelise, Guilhot, François, Turhan, Ali G.
Gepubliceerd in Blood (2011)

High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients

door Delord, Marc, Rousselot, Philippe, Cayuela, Jean Michel, Sigaux, François, Guilhot, Joëlle, Preudhomme, Claude, Guilhot, François, Loiseau, Pascale, Raffoux, Emmanuel, Geromin, Daniela, Génin, Emmanuelle, Calvo, Fabien, Bruzzoni-Giovanelli, Heriberto
Gepubliceerd in 2013

The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia

door Jacomet, Florence, Cayssials, Emilie, Barbarin, Alice, Desmier, Deborah, Basbous, Sara, Lefèvre, Lucie, Levescot, Anaïs, Robin, Aurélie, Piccirilli, Nathalie, Giraud, Christine, Guilhot, François, Roy, Lydia, Herbelin, André, Gombert, Jean-Marc
Gepubliceerd in Front Immunol (2017)

Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study

door Shah, Neil P., Guilhot, François, Cortes, Jorge E., Schiffer, Charles A., le Coutre, Philipp, Brümmendorf, Tim H., Kantarjian, Hagop M., Hochhaus, Andreas, Rousselot, Philippe, Mohamed, Hesham, Healey, Diane, Cunningham, Michael, Saglio, Giuseppe
Gepubliceerd in Blood (2014)

Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib

door Hughes, Timothy P., Saglio, Giuseppe, Kantarjian, Hagop M., Guilhot, François, Niederwieser, Dietger, Rosti, Gianantonio, Nakaseko, Chiaki, De Souza, Carmino Antonio, Kalaycio, Matt E., Meier, Stephan, Fan, Xiaolin, Menssen, Hans D., Larson, Richard A., Hochhaus, Andreas
Gepubliceerd in Blood (2014)

Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imati...

door Hughes, Timothy P., Hochhaus, Andreas, Kantarjian, Hagop M., Cervantes, Francisco, Guilhot, François, Niederwieser, Dietger, le Coutre, Philipp D., Rosti, Gianantonio, Ossenkoppele, Gert, Lobo, Clarisse, Shibayama, Hirohiko, Fan, Xiaolin, Menssen, Hans D., Kemp, Charisse, Larson, Richard A., Saglio, Giuseppe
Gepubliceerd in 2014

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

door Hochhaus, Andreas, Larson, Richard A., Guilhot, François, Radich, Jerald P., Branford, Susan, Hughes, Timothy P., Baccarani, Michele, Deininger, Michael W., Cervantes, Francisco, Fujihara, Satoko, Ortmann, Christine-Elke, Menssen, Hans D., Kantarjian, Hagop, O’Brien, Stephen G., Druker, Brian J.
Gepubliceerd in N Engl J Med (2017)

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interf...

door Hughes, Timothy P., Hochhaus, Andreas, Branford, Susan, Müller, Martin C., Kaeda, Jaspal S., Foroni, Letizia, Druker, Brian J., Guilhot, François, Larson, Richard A., O'Brien, Stephen G., Rudoltz, Marc S., Mone, Manisha, Wehrle, Elisabeth, Modur, Vijay, Goldman, John M., Radich, Jerald P.
Gepubliceerd in 2010

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

door Baccarani, Michele, Cortes, Jorge, Pane, Fabrizio, Niederwieser, Dietger, Saglio, Giuseppe, Apperley, Jane, Cervantes, Francisco, Deininger, Michael, Gratwohl, Alois, Guilhot, François, Hochhaus, Andreas, Horowitz, Mary, Hughes, Timothy, Kantarjian, Hagop, Larson, Richard, Radich, Jerald, Simonsson, Bengt, Silver, Richard T., Goldman, John, Hehlmann, Rudiger
Gepubliceerd in J Clin Oncol (2009)